supplementsWomen who develop more breast cysts upon the beginning of estrogen therapy should Women with breast cysts who develop more upon beginning estrogen should stopSecondary prevention is an approach focusing on early detection of cancer, thus increasing chances of cure, rather than preventing it altogetherPrimary prevention is an approach which attempts to stop the disease before it appearsA study known as the breast cancer prevention trial provided evidence that the drug tamoxifen reduces risk of breast cancer. The final data showed a fifty percent decrease in the risk for noninvasive cancer and a 49 percent decrease in the risk of invasive cancerThe FDA approved the use of tamoxifen for risk reduction for women who meet the criteria of the studyIt is not known if cancer is prevented forever or only suppressed for a timeHowever, use of tamoxifen appears to increase risk of uterine cancerRaloxifen is a drug related to tamoxifen but is claimed to have no adverse effect on the uterine. It seems promising, but has not yet been proven to be more effective than tamoxifen, or to have less side effectsthe national cancer institute has undertaken a five year study, called the STAP trial, comparing the preventive benefits of tamoxifen and raloxifenwomen at extremely high risk for developing breast cancer are sometimes advised to have a prophylactic mastectomy, or a mastectomy before any sign of cancerprophylactic mastectomies should be considered in the following cases-women who have undergone several biopsies so the breast is severely deformed-women whose mammograms show findings that are increasingly hard interpret-women whose breast biopsies do not indicate cancer but do show severe cell atypia, which is a strong risk factorNot much is known about the prevention of breast cancer.-there is no evidence psychological attitude causes cancer-incidence of breast cancer increased from sixties through eighties and stopped in the nineties-184,20...
